Unichem Laboratories is currently trading at Rs 177.75, up by 0.75 points or 0.42% from its previous closing of Rs 177.00 on the BSE.
The scrip opened at Rs 177.00 and has touched a high and low of Rs 180.45 and Rs 175.00 respectively. So far 20808 shares were traded on the counter.
The BSE group 'B' stock of face value Rs 2 has touched a 52 week high of Rs 203.35 on 25-Sep-2012 and a 52 week low of Rs 101.15 on 13-Dec-2011.
Last one week high and low of the scrip stood at Rs 181.70 and Rs 173.10 respectively. The current market cap of the company is Rs 2107.08 crore.
The promoters holding in the company stood at 49.53% while Institutions and Non-Institutions held 13.95% and 36.52% respectively.
Unichem Laboratories has received ANDA tentative approval from the United States Food and Drugs Administration (USFDA) for Irbesartan. Final approval will be received after the patent expires on Dec 7, 2015.
Irbesartan Tablets 75mg, 150mg and 300mg are therapeutically equivalent to Avapro Tablets 75mg, 150mg and 300mg from Sanofi Aventis US, LLC. Irbesartan is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.
The product will be commercialized (after the final approval) from Unichem's Ghaziabad plant, Active pharmaceutical ingredient i.e., Irbesartan used for this ANDA is also made in house at Pithampur plant. The current market size is $450 million.
Unichem Laboratories, incorporated in 1962, is engaged in manufacturing formulations, pharmaceuticals and active pharmaceutical ingredients (APIs). The company was promoted by the late Amrut Mody, a pioneer in the Indian pharmaceuticals business.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1751.05 |
Dr. Reddys Lab | 1163.70 |
Cipla | 1515.45 |
Lupin | 1936.75 |
Zydus Lifesciences | 831.40 |
View more.. |